Literature DB >> 17003302

Mortality and hospitalization in patients after amputation: a comparison between patients with and without diabetes.

Christopher J Schofield1, Gillian Libby, Geraldine M Brennan, Ritchie R MacAlpine, Andrew D Morris, Graham P Leese.   

Abstract

OBJECTIVE: We sought to compare the risk of mortality and hospitalization between patients with and without diabetes following incident lower-extremity amputation (LEA). RESEARCH DESIGN AND METHODS: We performed a retrospective data-linkage review of all incident amputations between 1 January 1992 and 31 December 1995. Patients were categorized according to their diabetes status. Follow-up for mortality was until 1 January 2005 and until 31 March 1996 for hospitalization.
RESULTS: Of 390 major-incident LEAs performed during the study period, 119 (30.5%) were in patients with diabetes and 271 (69.5%) were in nondiabetic subjects. The median time to death was 27.2 months in patients with diabetes compared with 46.7 months for patients without (P = 0.01). Diabetic subjects had a 55% greater risk of death than those without diabetes. The risk of developing congestive cardiac failure with diabetes was 2.26 (95% CI 1.12-4.57) and of further amputation was 1.95 (1.14-3.33) times that of a patient without diabetes after incident LEA.
CONCLUSIONS: After LEA, patients with diabetes have an increased risk of death compared with nondiabetic patients. Efforts should be made to minimize these risks with aggressive treatment of cardiovascular risk factors and management of cardiac failure.

Entities:  

Mesh:

Year:  2006        PMID: 17003302     DOI: 10.2337/dc06-0926

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  43 in total

1.  Self-reported use of complementary and alternative medicine (CAM) products in topical treatment of diabetic foot disorders by diabetic patients in Jeddah, Western Saudi Arabia.

Authors:  Balkees A Bakhotmah; Hasan A Alzahrani
Journal:  BMC Res Notes       Date:  2010-10-06

2.  Multimodal therapy as an algorithm to limb salvage in diabetic patients with large heel ulcers.

Authors:  Ewan B Goudie; Cynthia Gendics; John C Lantis
Journal:  Int Wound J       Date:  2011-09-23       Impact factor: 3.315

3.  Clinical outcomes of toe amputation in patients with type 2 diabetes in Tianjin, China.

Authors:  Yue-Jie Chu; Xi-Wen Li; Peng-Hua Wang; Jun Xu; Hao-Jie Sun; Min Ding; Jiao Jiao; Xiao-Yan Ji; Shu-hong Feng
Journal:  Int Wound J       Date:  2014-03-14       Impact factor: 3.315

4.  Survival evaluation of the patients with diabetic major lower-extremity amputations.

Authors:  Ü Gök; Ö Selek; A Selek; A Güdük; M Ç Güner
Journal:  Musculoskelet Surg       Date:  2016-03-10

5.  Non traumatic lower extremity amputations in younger patients: an 11-year retrospective study.

Authors:  Jessica W S Chin; Laura Teague; Ann-Marie McLaren; James L Mahoney
Journal:  Int Wound J       Date:  2012-02-13       Impact factor: 3.315

Review 6.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

7.  Low Back Pain in Adults With Transfemoral Amputation: A Retrospective Population-Based Study.

Authors:  Marianne Luetmer; Benjamin Mundell; Hilal Maradit Kremers; Sue Visscher; Kurtis M Hoppe; Kenton R Kaufman
Journal:  PM R       Date:  2019-04-01       Impact factor: 2.298

8.  Fewer major amputations among individuals with diabetes in Finland in 1997-2007: a population-based study.

Authors:  Tuija S Ikonen; Reijo Sund; Maarit Venermo; Klas Winell
Journal:  Diabetes Care       Date:  2010-08-31       Impact factor: 19.112

Review 9.  Diabetic foot ulcers treated with hyperbaric oxygen therapy: a review of the literature.

Authors:  Alexandra J Bishop; Elizabeth Mudge
Journal:  Int Wound J       Date:  2012-07-02       Impact factor: 3.315

10.  A Canadian population-based description of the indications for lower-extremity amputations and outcomes.

Authors:  Ahmed Kayssi; Charles de Mestral; Thomas L Forbes; Graham Roche-Nagle
Journal:  Can J Surg       Date:  2016-04       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.